You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A Chinese court has sentenced He Jiankui and two others to three years in jail for editing the genomes of infants as embryos.
A number of genomics studies made headlines in the 2010s and more are predicted to do so in the coming year.
Researchers have made gene-edited tomatoes that grow in bunches like grapes, as Popular Mechanics reports.
Two recent CRISPR-Cas9 viability screens in cancer cell lines were concordant across multiple metrics despite significant differences in experimental protocols.
Promega said it plans to use the technology to create new research products for investigating endogenous biology.
An editorial in the South China Morning Post seeks to learn from the He Jiankui gene-editing affair.
The companies will identify and optimize novel CRISPR proteins owned by Mammoth, and then license those proteins to Horizon for use in engineered cell lines.
Gene editing could be an issue competitive sports need to address soon, four researchers from Arizona State University write at Slate.
In Nature this week: genetic "clock" that can predict the lifespans of vertebrates, new assembler called wtdbg2, and more.
Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.
NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.
According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.
In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.
Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.